Department of Pharmacology, Bangabandhu Sheikh Mujib Medical University
Dhaka, 1000, Bangladesh
NCT Number: NCT01726426
The role of anaerobic bacteria in the pathogenesis of palmer arsenical keratosis is not known. This can be evaluated by administering probiotics. Thirty patients from an arsenic affected area will be provided two probiotics capsules per day orally for 12 weeks and stool samples will be collected for qualitative and quantitative analysis of anaerobic bacteria. Similar number of arsenic exposed controls and healthy volunteers from the same area will be included with similar protocol for comparison. Like aerobic bacteria, anaerobic bacteria may be modulated by probiotics in arsenicosis patients.
Looking for future studies?
Notify Me20 year–60 year
All sexes
Interventional
Not applicable
Dhaka, 1000, Bangladesh
Recent study done by our laboratory shows that there are reduction in the number of E. coli in the gut of patients with arsenical keratosis which is increase by the administration of probiotics (manuscript is preparing). However, E.coli contribute only about 0.1% of the total gut bacteria. It is not known whether anaerobic bacteria play an important role in the pathogenesis of arsenical keratosis. This can be evaluated by administering probiotics. Thirty patients of moderate arsenical palmer keratosis from an arsenic affected area will be recruited on the basis of inclusion and exclusion criteria. They will be provided two probiotics capsules per day orally for 12 weeks. Water sample will be collected before starting the study for confirming the diagnosis. Stool samples will be collected twice (before and after completion of the study) for qualitative and quantitative analysis of anaerobic bacteria. Similar number of arsenic exposed controls (30) and healthy volunteers (30) from the same area will be included in this study and they will be provided probiotics capsules with similar dosage and duration. Like aerobic bacteria, anaerobic bacteria may be modulated by probiotics in arsenicosis patients.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
(Patients):
Inclusion criteria
(Arsenic exposed controls):
Inclusion criteria
(Healthy volunteers):
Exclusion criteria
Each capsule Probiotics (Lactobacillus- 2 billion, Bifidobacterium- 1 billion, fructo-oligosaccharide): 1 capsule twice daily orally for 12 weeks
Time frame: 0 weeks (baseline), 12 weeks (end)
Number of pathogenic anaerobic bacteria in the stool of patients will be decrease in comparison to arsenic exposed controls and volunteers after 12 weeks supplementation with probiotics.
Time frame: 0 week (baseline), 12 weeks (end)
Arsenic level in the stool of patients will be increased in comparison to arsenic exposed controls and healthy volunteers. Arsenic level will be estimated using Atomic Fluorescence spectrometer.
Time frame: 0 week (baseline), 12 weeks (end)
There will be improvement of moderate palmer keratosis following supplementation with probiotics.
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
Other
Modulation of Anaerobic Gut Bacteria in Palmer Arsenical Keratosis Patients by Supplementation With Probiotics
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03127657
Chronic Arsenic Poisoning
Chāndpur, Bangladesh
View Trial DetailsNCT02908581
Chronic Arsenic Poisoning
Comilla, Bangladesh
View Trial DetailsNCT02352987
Chronic Arsenic Poisoning
Comilla, Bangladesh
View Trial DetailsNCT02468518
Chronic Arsenic Poisoning
Comilla, Bangladesh
View Trial Details